China Baoyuan and CNNC Relationship is a sub-parent company.
China Baogen Investment Company Limited is a wholly-owned subsidiary of China National Nuclear Corporation. Ltd. is a wholly-owned subsidiary of China National Nuclear Corporation (CNNC), which centers on the whole industrial chain of nuclear technology application, starting from nuclear, more than nuclear, and constructs three major industrial systems, namely, nuclear technology products and services, nuclear specialties and medical treatment, and modern services, by investing in and controlling the source, strengthening the core, and expanding the application of the strategic path.
ChinaBaoyuan, as a specialized company of China National Nuclear Corporation (CNNC) for the development of nuclear technology application industry, is committed to letting nuclear technology create happiness for human beings, and is responsible for the implementation of the medium- and long-term strategic objectives of the development of CNNC's nuclear technology application industry, and to build an internationally renowned nuclear technology application industry group. China Baoyuan has more than 200 member units distributed in more than 10 large and medium-sized cities, including Beijing, Shenzhen, Suzhou, Chengdu, Qingdao, Xi'an, Nanjing, etc., with its headquarter located in Beijing.
China Baoyuan Investment Company Profile:
China Baoyuan Investment Company Limited (China Baoyuan for short) is a wholly-owned specialized company for the development of the nuclear technology application industry of China National Nuclear Corporation (CNNC), and is responsible for the implementation of the medium- and long-term development strategy of the nuclear technology application industry of CNNC. The predecessor of the company can be traced back to the Sixth Bureau of the Second Machine Department. Currently, China Baoyuan's business covers most of the fields of nuclear technology application, forming a nuclear technology application industry chain from technology, products to service application.
China Baoyuan serves more than 10,000 medical institutions nationwide, with a domestic market share of more than 70%; its 14C breath diagnostic products account for more than 90% of the domestic market share, and its 13C breath diagnostic products account for more than 50% of the domestic market share; it has mastered the technology of independent production of medical 60Co source, with a market share of 90%; and the annual output of industrial 60Co is about seven million curies, ranking the third in the world. The annual output of industrial 60Co is about 7 million curies, ranking the third in the world.
Reference: Baidu Encyclopedia-China Baoyuan Investment Co.